drugset / Trial / NCT06525948

Efficacy and Safety of rhTPO in Combination With Cyclosporine Versus Cyclosporine Alone in the Treatment of TD-NSAA

NCT06525948

Phase 4 Not yet recruiting 54 enrolled Peking Union Medical College Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

Investigating the efficacy and safety of rhTPO in combination with cyclosporine versus cyclosporine alone for the treatment of TD-NSAA

Timeline

Start
2024-07-30
Primary completion
2025-06-30
Completion
2025-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyclosporine Peptide
Subject recombinant human thrombopoietin Protein / enzyme biologic

Indications